9/11 Firemen More Prone to Cancer

Firefighters who worked at the World Trade Center during the terrorist attacks of 9/11 and the event’s aftermath have higher rates of cancer.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Firefighters at Ground ZeroFLICKR, BEVERLY & PACK

New York City firefighters who worked at the World Trade Center on September 11 and afterwards during the recovery have higher cancer rates than colleagues who were never called to the site, according to a study in The Lancet.

The researchers looked at the medical records of 9,583 NYC firefighters. Compared to similar workers who never worked at Ground Zero, those who did had a 19 percent higher cancer rate, and a 10 percent higher rate than a similar subset of the general population. The dust from the collapse of the towers contained several carcinogens such as dioxin, so it’s plausible that it could have fueled higher cancer rates, the authors say. Such carcinogens can both cause cancer directly by acting as mutagens on a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies